All articles
Assisted livingAugust 23, 2026 · 5 min read

Acuity Intelligence: See Rising Care Needs the Moment They Rise

Residents' needs rise faster than periodic assessments capture. BioAlign turns continuous monitoring into an objective acuity score and flags when a resident's needs have increased — decision-support that makes rising care levels visible and defensible.

Care needs do not wait for the next scheduled assessment. A resident's mobility slips, their nights get more restless, the near-misses start adding up — and the periodic manual assessment, done every so often, only catches it at the next review. In the gap, facilities routinely deliver more care than their records reflect.

An objective, continuous acuity score

BioAlign turns its continuous functional monitoring into an objective care-level (acuity) score for each resident — built from gait and mobility, fall history, functional assessments (STEADI/FMS), and nighttime activity. Instead of a snapshot taken once in a while, it is a living measure of how much care a resident actually needs.

Alerts when needs change

When a resident's needs rise since their last assessment, BioAlign surfaces it — so a care-level review happens because the data called for it, not because the calendar came around. It assembles a reassessment evidence pack automatically: the trends, fall counts, and mobility changes that support the review, exportable to share with families. A facility-wide acuity dashboard rolls it up for staffing decisions.

Why it matters

Rising acuity that no one has documented is both a care risk and a business problem. Making it visible and defensible helps your team match staffing to real need, supports an honest care-level conversation with families, and puts objective evidence behind decisions that used to rest on gut feel. It is decision-support for the care team — not a replacement for the clinical assessment.

And it runs where the rest of BioAlign runs: on the on-site appliance, so resident data never leaves the building.

BioAlign Care is a validated screening aid in active validation — not an FDA-cleared diagnostic. Acuity scoring is decision-support, not a clinical or billing determination. KinovaAI LLC, Fresno, CA.

See how this works in your building.

A 30-minute walkthrough of the live platform, plus a tailored ROI estimate — no obligation.